Adopting new technology could help pharma and biotech firms fix the expensive and lengthily drug development process, writes Rahul Bhushan.
Tag: ARK
The FSA Spy market buzz – 12 January 2024
Bitcoin ETFs off the leash, Federated Hermes’s new ETF, Apple vs Microsoft, Alliance Bernstein’s results, India’s vast online buyers, Pinebridge on AI, Who owns the US stock market and much more.
Morningstar warns about ARK Innovation ETF risks
The fund research firm’s report emphasises an ad hoc investment process highly dependent on its founder fund manager.
